In terms of survival analysis, high expression of CDK6-AS1 was related to poor prognosis in BLCA, HNSC, KIRC, LGG, LUAD, MESO, and THCA (Figures 5B–H), while showing better prognosis in UVM (Figure 5I). The gene discussed is CDK6; the disease is bladder transitional cell carcinoma.